Masaki Okamoto Selected Research

Therapeutics

12/2021	Phase II Clinical Trial of Combination Therapy with Favipiravir and Methylprednisolone for COVID-19 with Non-Critical Respiratory Failure.
2/2021	Investigation of Factors Affecting Early Quality of Life of Patients after Breast Cancer Surgery.
10/2020	Two- and three-photon excitable quaternized imidazo[1,2-a]pyridines as mitochondrial imaging and potent cancer therapy agents.
4/2018	Successful Treatment of Rapidly Progressive Unclassifiable Idiopathic Interstitial Pneumonia with Anti-melanoma Differentiation-associated Gene-5 Antibody by Intensive Immunosuppressive Therapy.
2/2011	[A case of pulmonary Langerhans cell histiocytosis with panhypopituitarism].
9/2006	[A case of pulmonary adenocarcinoma accompanied by minimal change nephrotic syndrome, antiphospholipid syndrome and warm-type autoimmune hemolytic anemia].
7/2006	[A case of cryptogenic organizing pneumonia accompanied by large bullae].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masaki Okamoto Research Topics

Disease

12	Idiopathic Pulmonary Fibrosis 05/2021 - 12/2004
8	Interstitial Lung Diseases (Interstitial Lung Disease) 10/2021 - 02/2002
8	Asthma (Bronchial Asthma) 05/2019 - 08/2007
7	Chronic Obstructive Pulmonary Disease (COPD) 03/2020 - 10/2012
7	Lung Injury 01/2019 - 02/2002
6	Fibrosis (Cirrhosis) 07/2020 - 11/2003
6	Inflammation (Inflammations) 05/2019 - 09/2003
4	Respiratory Insufficiency (Respiratory Failure) 01/2022 - 12/2005
4	Idiopathic Interstitial Pneumonias 01/2022 - 01/2010
4	Neoplasms (Cancer) 02/2021 - 01/2009
4	Bronchiectasis 01/2021 - 01/2013
4	Pneumonia (Pneumonitis) 01/2013 - 08/2007
3	COVID-19 01/2022 - 01/2021
3	Tuberculosis (Tuberculoses) 01/2020 - 07/2002
3	Dyspnea (Shortness of Breath) 01/2016 - 02/2011
3	Respiratory Hypersensitivity 01/2013 - 08/2007
3	Infections 01/2013 - 07/2002
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2012 - 01/2009
3	Airway Remodeling 09/2009 - 08/2007
2	Breast Neoplasms (Breast Cancer) 08/2021 - 02/2021
2	Systemic Scleroderma (Systemic Sclerosis) 03/2021 - 01/2017
2	Disease Progression 07/2020 - 01/2019
2	Eosinophilia 05/2019 - 01/2010
2	Melanoma (Melanoma, Malignant) 01/2017 - 01/2016
2	Atopic Dermatitis (Atopic Eczema) 01/2017 - 10/2012
2	Dermatomyositis (Dermatopolymyositis) 01/2017 - 01/2015
2	Rheumatoid Arthritis 12/2015 - 10/2012
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2013 - 05/2012
2	Hyperplasia 04/2011 - 09/2009
2	Neoplasm Metastasis (Metastasis) 01/2009 - 01/2006
2	Fever (Fevers) 07/2006 - 12/2005
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022
1	Immunoglobulin G4-Related Disease 01/2022
1	Diarrhea 03/2021
1	Liver Diseases (Liver Disease) 01/2021
1	Critical Illness (Critically Ill) 01/2021
1	Guillain-Barre Syndrome 09/2020
1	Cough 09/2020
1	Pulmonary Sarcoidosis 07/2020
1	Pulmonary Arterial Hypertension 01/2020

Drug/Important Bio-Agent (IBA)

12	CytokinesIBA 01/2022 - 02/2002
12	Proteins (Proteins, Gene)FDA Link 05/2019 - 07/2002
12	Interleukin-18 (Interleukin 18)IBA 03/2014 - 02/2002
7	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2021 - 07/2006
6	Bleomycin (Blenoxane)FDA LinkGeneric 01/2019 - 11/2003
6	ThioredoxinsIBA 01/2010 - 11/2003
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2013
5	PeriostinIBA 05/2021 - 05/2012
5	AntibodiesIBA 01/2019 - 12/2005
5	ChemokinesIBA 05/2012 - 02/2002
4	nintedanibIBA 10/2021 - 06/2019
4	AntigensIBA 01/2013 - 08/2007
4	Interleukin-2 (IL2)IBA 04/2008 - 02/2002
3	Interleukin-13IBA 03/2014 - 08/2007
3	Interleukin-18 ReceptorsIBA 01/2014 - 02/2002
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 04/2011
2	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 09/2003
2	Methylprednisolone FDA LinkGeneric 12/2021 - 02/2011
2	Dexamethasone (Maxidex)FDA LinkGeneric 12/2021 - 08/2009
2	Carbon MonoxideIBA 01/2020 - 02/2011
2	AcidsIBA 01/2020 - 05/2013
2	Tyrosine Kinase InhibitorsIBA 06/2019 - 09/2017
2	Monoclonal AntibodiesIBA 09/2017 - 01/2013
2	Pharmaceutical PreparationsIBA 09/2017 - 12/2009
2	Indicators and Reagents (Reagents)IBA 01/2017 - 01/2016
2	Immunosuppressive Agents (Immunosuppressants)IBA 11/2016 - 08/2006
2	Surface-Active Agents (Surfactants)IBA 03/2015 - 03/2014
2	OvalbuminIBA 01/2013 - 08/2007
2	C-Reactive ProteinIBA 04/2011 - 12/2005
2	Itraconazole (Sporanox)FDA LinkGeneric 03/2006 - 12/2005
2	Micafungin (FK463)FDA Link 03/2006 - 12/2005
2	InterleukinsIBA 12/2004 - 11/2003
1	fibrin fragment D (D-dimer)IBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	favipiravirIBA 12/2021
1	Acetylcysteine (Siran)FDA LinkGeneric 01/2021
1	pirfenidoneIBA 01/2021
1	PyridinesIBA 10/2020
1	Intravenous Immunoglobulins (IVIG)FDA Link 09/2020
1	Anesthetics (Anesthetic Agents)IBA 09/2020
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 07/2020
1	Budesonide (Pulmicort)FDA LinkGeneric 07/2020
1	Periodic AcidIBA 07/2020
1	AsbestosIBA 07/2020
1	OligosaccharidesIBA 03/2020
1	Telomerase (Telomerase Reverse Transcriptase)IBA 03/2020
1	Fluorescent Dyes (Fluorescent Probes)IBA 03/2020
1	telomerase RNA (bTR)IBA 03/2020
1	RNA (Ribonucleic Acid)IBA 03/2020
1	OligonucleotidesIBA 03/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	ThrombomodulinIBA 01/2020

Therapy/Procedure

8	Drug Therapy (Chemotherapy) 02/2021 - 01/2006
7	Therapeutics 12/2021 - 07/2006
4	Traction 01/2021 - 01/2013
2	Artificial Respiration (Mechanical Ventilation) 01/2022 - 01/2021
2	Lymph Node Excision (Lymph Node Dissection) 08/2021 - 02/2021
1	Radiotherapy 02/2021
1	Neoadjuvant Therapy 02/2021
1	Noninvasive Ventilation 01/2021